Assistant Professor, Immunology Frontier Research Center, Osaka University*Profile is at the time of the award.
2023Inamori Research GrantsBiology & Life sciences
Pulmonary fibrosis is a refractory condition, marked by an unfavorable prognosis, with nearly 50% of patients succumbing within a span of 3 to 5 years post-diagnosis. Regrettably, a definitive cure for this affliction remains elusive to date. The current investigation aims to shed light on the underlying molecular mechanisms of pulmonary fibrosis, an ailment for which no efficacious therapeutic interventions currently exist. By delineating the pathophysiological underpinnings of this disease, this research endeavors to facilitate the development of novel molecular therapies, based on a deeper comprehension of its molecular etiology.
Biology & Life sciences
